https://admin.adbutler.com/?ID=173641&p=campaign.view&advID=123603&campaignID=354382
GILD Surges: Trodelvy’s Approval Could Transform Oncology!
Overview Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company long known for its HIV and antiviral therapies, now aggressively expanding into oncology. In early 2023,
